✦ LIBER ✦

Combination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinoma

✍ Scribed by T. Himoto; Seishiro Watanabe; Mikio Nishioka; Takashi Maeba; Satoshi Tanaka; Motoo Saito

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 756 KB
Volume: 42
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s002620050262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Therapy With Recombinant Hum

Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia

✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

An application of recombinant human gran

An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization

✍ Furukawa, Hiroyoshi ;Hara, Tsuyoshi ;Hoshino, Kazuhiko ;Taniguchi, Tetsushi 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 701 KB

Short term treatment with Escheria coli

Short term treatment with Escheria coli recombinant human granulocyte-macrophage–colony stimulating factor prior to chemotherapy for Hodgkin disease

✍ M. Aglietta; F. Montemurro; F. Fagioli; C. Volta; B. Botto; M. Cantonetti; V. Ra 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## BACKGROUND. Granulocyte-macrophage-colony stimulating factor (GM-CSF) administration stimulates the proliferation of hemopoietic progenitors. Shortly (48 -96 hours) after its discontinuation, feedback phenomena occur and the progenitor proliferation rate drops below baseline levels. As the quies

Long-term Follow-up of Patients with Apl

Long-term Follow-up of Patients with Aplastic Anemia and Refractory Anemia Responding to Combination Therapy with Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin

✍ Akira Matsuda; Kuniya Kishimoto; Katsuhiko Yoshida; Fumiharu Yagasaki; Yoshihiro 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 120 KB

Granulocyte-macrophage–colony stimulatin

Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f

A phase II study of irinotecan and infus

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Suguru Machida; Takeshi Yoshida; Munehide Yoshida; Yasuliko Kano; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB